Back

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in HFrEF.

26 May 2019 (10:36 - 10:42)
Organised by:
Congress Presentation Part of: Moderated Poster Session - Chronic heart failure Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Pieter Martens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

8 More presentations in this session

Presentation thumbnail
Association between heart failure medication at discharge and heart failure readmission
Doctor G. Linssen (Almelo, NL)
Abstract Slides
Presentation thumbnail
Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis involving 48,628 patients
Doctor C. Kapelios (Athens, GR)
Abstract Slides
Presentation thumbnail
Combined effects of growth hormone and testosterone replacement treatment in heart failure
Doctor A. Salzano (Naples, IT)
Presentation thumbnail
FE- IRON (First Ever Irish heart failure nurses group Review On implementation of ESC iroN guideline in Ireland)
Ms M. Carey (Dublin, IE)
Abstract Slides
Presentation thumbnail
Effect of ferric carboxymaltose on LVEF as assessed by cardiac MRI in patients with chronic heart failure and iron deficiency: a randomized, double-blinded, placebo-controlled, dual-center trial
Doctor M. Karakas (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Moderated Poster Session - Chronic heart failure

The Event

Event poster

Heart Failure 2019

26 May 2019 10:36 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources